No Carolina / NY / Florida
Ph: 561.316.3330

Lankenau Heart Institute, Part of Main Line Health, 1st in No America to Sign Long-term Strategic Partnership with Philips Utilizing Integrated Cardiovascular Solutions

Unique five-year agreement will help Philadelphia-based health leader integrate and standardize innovative cardiovascular care, helping to deliver on the quadruple aim

Summation

  • “Healthcare technology is evolving at a rapid rate and partnering with Main Line Health will allow us to understand patient needs and workflows, map them to the right solutions and help them to deliver on the quadruple aim,” said Vitor Rocha, Market Leader for Philips North America.
  • “Through this innovative business model, we will have a technology partner who can help us adopt the solutions that will not only help us drive operational efficiency, they will allow us to expand the type of quality care our patients have come to expect,” said Trudy Mazzone, MS, BSRT, (R), System Director, Main Line Health Cardiovascular Services and Co-director, Lankenau Heart Institute.
  • Working together, Philips and Main Line Health will develop an ecosystem of clinically-enabled cardiovascular solutions that will allow Main Line Health to standardize and integrate technology across its network, helping to unlock patient data for better clinical decisions, while optimizing workflows for a better patient and staff experience.

Lankenau Heart Institute part of Main Line Health, and Royal Philips today announced they have entered a five-year strategic partnership focused on integrated cardiovascular solutions.

Working together, Philips and Main Line Health will develop an ecosystem of clinically-enabled cardiovascular solutions that will allow Main Line Health to standardize and integrate technology across its network, helping to unlock patient data for better clinical decisions, while optimizing workflows for a better patient and staff experience. In addition, the partnership aims to help Main Line Health drive predictability and consistency in costs, as well as focus on clinical and technical training.  

Providing care to the Philadelphia region and its western suburbs, Main Line Health is committed to delivering advanced medicine to treat and cure disease, while also playing an important role in prevention strategies and disease management. At its core are four of the region’s most respected acute care hospitals – Lankenau Medical Center, Bryn Mawr Hospital, Paoli Hospital and Riddle Hospital. Moreover, Main Line Health conducts clinical research in the latest health care innovations and trains physicians and other health care providers to ensure its staff can provide the best, most advanced care to the communities they serve.

“Through this innovative business model, we will have a technology partner who can help us adopt the solutions that will not only help us drive operational efficiency, they will allow us to expand the type of quality care our patients have come to expect,” said Trudy Mazzone, MS, BSRT, (R), System Director, Main Line Health Cardiovascular Services and Co-director, Lankenau Heart Institute.

“By partnering with Philips, we will be able to continue our world-class cardiovascular care system-wide, including fully renovating and installing state-of-the-art Philips equipment to provide advanced cardiovascular and neuro care at Bryn Mawr Hospital and Paoli Hospital,” said William Gray, MD, System Chief, Cardiovascular Diseases, Main Line Health and Co-director, Lankenau Heart Institute. “This will allow us to define a strategy for the future, adopting novel technology as it evolves.”

This long-term strategic partnership will uniquely focus on integrated cardiovascular solutions. As part of the partnership, a dedicated team of Philips solutions architects will work collaboratively with Main Line Health to understand their challenges and develop technology plans around the cardiovascular service line. These technology plans are tailored to their needs with three objectives in mind: clinical, operational, and business model innovation.

Philips brings over a century of experience in healthcare, providing best practices in world-class facility planning and design, intelligent technology implementation, data analytics and IT integration, and education management, as well as workflow and performance optimization.

“Healthcare technology is evolving at a rapid rate and partnering with Main Line Health will allow us to understand patient needs and workflows, map them to the right solutions and help them to deliver on the quadruple aim,” said Vitor Rocha, Market Leader for Philips North America. “Together we can help them keep pace with technology, allowing them to focus on what is most important: providing high-quality care, positive patient outcomes and a superior patient experience for their community.”

Medical Device News Magazinehttps://infomeddnews.com
Medical Device News Magazine provides breaking medical device / biotechnology news. Our subscribers include medical specialists, device industry executives, investors, and other allied health professionals, as well as patients who are interested in researching various medical devices. We hope you find value in our easy-to-read publication and its overall objectives! Medical Device News Magazine is a division of PTM Healthcare Marketing, Inc. Pauline T. Mayer is the managing editor.

- Advertisement -

spot_img

- Advertisement -

New Inflammatory Bowel Disease Center Opens at Northwell Health

The new Inflammatory Bowel Disease Center, located at 125 Community Drive in Manhasset, has 13 exam rooms, two procedural rooms and six infusion bays. Since it started operations, people have travelled from all over the country – and as far away as Alaska – to receive high-quality care.

Cold Spring Harbor Laboratory and Northwell Health Extend Strategic Affiliation

“The alliance between Cold Spring Harbor Laboratory (CSHL) and Northwell Health brings transformative bioscience research into the clinic,” says CSHL President & CEO Bruce Stillman. “As New York’s largest healthcare provider, Northwell Health serves a remarkably diverse patient population. This agreement will provide patient communities with greater access to cutting-edge biomedical technology, allowing for more precise diagnoses and treatments, and ultimately facilitating new breakthroughs in cancer care.”

Hackensack Meridian Neuroscience Institute at JFK University Medical Center Receives $2.2 Million Research Grant to Study A Novel Traumatic Brain Injury Treatment

The NIH grant will fund a project entitled “Neutrophil Extracellular Traps And Associated Pathogenesis In TBI: A Novel Peptide Therapeutic Strategy” proposed by Mohammed Abdul Muneer, MSc, PhD, Research Scientist & Principal Investigator, Hackensack Meridian Neuroscience Institute at JFK University Medical Center, and Associate Professor of Neurology at the Hackensack Meridian School of Medicine.

By using this website you agree to accept Medical Device News Magazine Privacy Policy